The Lovisenberg Open Acute Door Study (LOADS): a trial of an open-door policy for psychiatric wards

ISRCTN ISRCTN16876467
DOI https://doi.org/10.1186/ISRCTN16876467
Secondary identifying numbers RCN 309903
Submission date
29/01/2021
Registration date
29/01/2021
Last edited
11/03/2024
Recruitment status
Recruiting
Overall study status
Ongoing
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
Freedom of movement is a fundamental human right that is systematically restricted in acute psychiatry to address safety, prognosis and/or staffing concerns. The legitimacy and therapeutic impact of the current state-of-the art ‘locked door’ practice has recently been called into question by the United Nations, the WHO, user organisations, and the Norwegian Government. In this study, the Lovisenberg Diaconal Hospital will implement and test a new service model, open-door policy, to investigate their potential to reduce coercion on our inner-city acute psychiatric wards.

Who can participate?
Adults 18 - 65 years, referred to an acute psychiatric ward from a psychiatric intensive care unit.

What does the study involve?
In this healthcare services RCT, the Lovisenberg Open Acute Door Study (LOADS), staff will randomly assign admitted acute psychiatric patients to two open-door policy wards or three state-of-the-art locked-door wards for 12 months. The RCT will be followed by a 4-year observational period to report on any post RCT effects on violent and coercive events, patient feedback, or the treatment stay (duration, type/intensity of treatments received, readmission). All wards are located in the same building facility at Lovisenberg campus in Oslo, Norway. The hypothesis is that open-door care will be equivalent to locked-door care on safety and coercive measures, and equivalent- or superior to locked-door care on patient experiences of treatment.

What are the possible benefits and risks of participating?
The benefit may be an improvement in care.
The risk of participating in any study arm can be considered equivalent to or better than standard care, as Lovisenberg's regular (locked-door) services have previously been acclaimed for user-orientation and ability to minimise coercion.
Standard clinical data (including patient feedback/experience measures) will be utilised.

Where is the study run from?
Lovisenberg Diaconal Hospital Clinic of Psychiatry (Norway)

When is the study starting and how long is it expected to run for?
February 2020 to December 2025

Who is funding the study?
1. Lovisenberg Diaconal Hospital (Norway)
2. The Research Council of Norway
3. The South-Eastern Norway Regional Health Authority

Who is the main contact?
Nikolaj Kunøe, nku@lds.no

Contact information

Mr Nikolaj Kunøe
Scientific

Lovisenberg Diaconal Hospital
Postboks 4970 Nydalen
Oslo
0440
Norway

ORCiD logoORCID ID 0000-0003-4530-2021
Phone +47 23226000
Email nku@lds.no
Mr Hans Martin Nussle
Public

Lovisenberg Diaconal Hospital
Postboks 4970 Nydalen
Oslo
0440
Norway

Phone +47 23226000
Email hansmartin.nussle@lds.no

Study information

Study designInterventional randomized controlled single-centre study with observational follow up
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typePrevention
Participant information sheet No participant information sheet available
Scientific titleThe Lovisenberg Open Acute Door Study: a randomised clinical trial of open-door policy services for ward-based, acute psychiatric healthcare services
Study acronymLOADS
Study hypothesisAn open-door policy service model does not cause more incidents of violence, coercive measures or suicide than a standard, locked-door service model.
Ethics approval(s)Approved as a healthcare services study with exemption from consent requirements on 02/02/2020, Regional Ethical Committee South-East D (P.O. Box 1130, Blindern, 0318 Oslo, Norway; +47 22 84 55 11; rek-sorost@medisin.uio.no), ref: 29328
ConditionMinimisation of violent incidents and of unnecessary coercive measures in acute inpatient treatment of patients with serious psychiatric disorders or states.
InterventionAll patients referred to acute ward care from an admissions ward or psychiatric intensive care unit (PICU) are randomly allocated to either:
1. Two wards with an open-door policy service model that provides peer service workers, treatment planning based on open dialogue with next of kin or collaborating outpatient/city services, and free mobility during daytime hours (09.00-21.00) through the ward door (contingent on frequent, accurate risk assessment)
2. Three wards with a standard, locked-door policy including de-escalation training. As a healthcare services trial, the type and duration of interventions are applied by ward staff based on individual assessment of the patient's needs.

To minimise the ethical and clinical burden of random allocation of patients to wards, patients returning from a recent (2020) admission are allocated using a 'home ward' principle, while new patients are allocated using a randomisation list. This randomised phase lasts 12 months, after which an observational phase commences during which more wards adopt the open-door policy model provided study hypotheses are supported. Standard acute ward observational statistics will be collected for monthly, quarterly, and annual reports for 4 years on violent and coercive events, types and doses of treatments, length of stay, unauthorised leave/absconding, patient feedback measures, readmission (time to- and general rates). The design permits pre-post analyses of effects as well as randomised parallel groups comparisons.
Intervention typeBehavioural
Primary outcome measureNumber of patient stays with one or more coercive measures (including involuntary medication, isolation/seclusion, mechanical- or manual/physical restraints) is measured by summarising registered coercive measures per study arm in patient records at 12 months (RCT), and (observational) 24, 36, and 48 months
Secondary outcome measures1. Violent events, including suicides, are measured using the hospital incident registry at 12 months, 24, 36, and 48 months
2. Individual coercive measures (including medications, seclusion, mechanical or manual/physical restraints) are measured using patient records and summarised at 12 months, 24, 36, and 48 months
3. Duration of separate involuntary/coercive measures are measured in patient records at 12 months (RCT), and (observational) 24, 36, and 48 months
4. Patients' experience of coercion and treatment environment are measured by patient-reported experience measures (PREMs) continuously and summarised at 12 months, 24, 36, and 48 months
5. Absconding from inpatient care is measured in the patient records of all involuntarily admitted patients at 12 months (RCT), and (observational) 24, 36, and 48 months
6. Type and extent of in-building use of illicit substances and alcohol abuse is measured by continuous on-site measuring of substances and metabolites in wastewater and comparing this to baseline (2020) samples.
7. Type and extent of pharmaceutical treatments are measured by patient records at 12 months (RCT), and (observational) 24, 36, and 48 months
8. The amount of time main doors are open to patients (as opposed to locked due to emergencies) is measured using in-ward door records at 12 months (RCT), and (observational) 24, 36, and 48 months
Overall study start date02/02/2020
Overall study end date31/12/2025

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit65 Years
SexBoth
Target number of participants500 (RCT)
Total final enrolment556
Participant inclusion criteria1. Adults aged 18 - 65 years
2. Referred to acute psychiatric ward from a psychiatric intensive care unit (PICU)
Participant exclusion criteria1. Forensic category patient (assessed as having a high risk of committing violence)
2. Police or criminal justice custody patient without legal option to utilise the open-door service
Recruitment start date10/02/2021
Recruitment end date31/12/2025

Locations

Countries of recruitment

  • Norway

Study participating centre

Lovisenberg Diaconal Hospital Clinic of Psychiatry
Lovisenberg Diakonale Sykehus
Postboks 4970 Nydalen
Oslo
0440
Norway

Sponsor information

Lovisenberg Diakonale Sykehus
Hospital/treatment centre

Postboks 4970 Nydalen
Oslo
0440
Norway

Phone +47 23 22 50 00
Email forskning@lds.no
Website http://lds.no/
ROR logo "ROR" https://ror.org/03ym7ve89

Funders

Funder type

Government

Norges Forskningsråd
Government organisation / National government
Alternative name(s)
Forskningsrådet, Norwegian Research Council, Research Council of Norway
Location
Norway
Helse Sør-Øst RHF
Government organisation / National government
Alternative name(s)
South-Eastern Norway Regional Health Authority, Southern and Eastern Norway Regional Health Authority, helsesorost, Helse Sør-Øst RHF, sorost
Location
Norway

Results and Publications

Intention to publish date15/07/2026
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot expected to be made available
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal during Q3-4 2022.
Follow-up publications in high-impact peer-reviewed journals from Q3 2022 until Q3 2026.
National / local dissemination in peer-reviewed and popular / public journals as well as video dissemination.
IPD sharing planThe datasets generated during and/or analysed during the current study are not expected to be made available.
The Privacy Ombudsman of Lovisenberg Diaconal Hospital has requested participant-level data not be made available to external parties due to the sensitive nature of psychiatric diagnoses and acute psychiatric admissions.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article 16/02/2022 17/02/2022 Yes No
Results article 06/03/2024 07/03/2024 Yes No

Editorial Notes

11/03/2024: Total final enrolment added.
07/03/2024: Publication reference added.
17/02/2022: Publication reference added.
29/01/2021: Trial’s existence confirmed by Regional Ethical Committee South-East D (Norway).